CIOReview Magazine has featured Verista as one of the top companies in their prominent listing of 10 Most Promising Pharma and Life Sciences Solution Providers – 2021. The positioning is based on Verista being a pioneer in this field, partnering with clients to facilitate compliance and safety across the entire product development continuum. The editorial board at CIOReview noted that the company provides operational, IT and validation expertise across systems, quality, and data integrity to fast track the drug development process.
The annual list of companies is selected by a panel of experts and members of CIOReview’s editorial board to recognize and promote technology entrepreneurship. “We are glad to announce Verista as one of the 10 Most Promising Pharma and Life Sciences Solution Providers 2021. We are pleased to recognize Verista as the company sits at the intersection of validation, compliance, quality and regulatory – managing and overseeing the complex aspects of business operations, processes and data integrity associated with these functions,” said Justin Smith, Managing Editor of CIOReview Magazine.
Recently, Verista worked with four COVID-19 vaccine manufacturers to help bring their therapies to the market in the shortest time possible. This was because Verista is compliance-focused and could rapidly understand the clients’ data and systems. Importantly, Verista’s agility and focus on data and system integrity made them the partner of choice. Verista also enables medical device manufacturers to speed up their time to market. With its dedicated hardware and software testing teams, the company assists clients with product testing prior to the pre-approval stages. The company provides the skillset to perform rigorous testing of product hardware and software under critical timelines, which are often key in meeting market demand.
To see the full list of the 10 Most Promising Pharma and Life Sciences Solution Providers, click here.
For the full interview with Verista CEO Manny Soman and CIOReview magazine, click here
